首页 >
法规速递
-
Page: Memantine product-specific bioequivalence guidance-2025/6/30
2025-07-01查看详情 > -
Document: Appendix 1: Acceptable intakes established for N-nitrosamines-2025/8/1
2025-08-04查看详情 > -
国家药监局关于发布国家医疗器械监督抽检结果的通告（2025年第35号）-2025/9/22
2025-09-23查看详情 > -
Page: Website outages and upgrades-2025/10/28
2025-10-29查看详情 > -
Cross-Center Master Files: Where to Submit-2025/11/25
2025-11-27查看详情 > -
国家药监局关于适用《E6（R3）：药物临床试验质量管理规范技术指导原则》国际人用药品注册技术协调会指导原则的公告（2025年第125号）-2025/12/24
2025-12-25查看详情 > -
Page: PRIME: priority medicines-2026/2/5
2026-02-06查看详情 > -
Document: QRD veterinary Appendix I - Adverse event (PhV) MSs reporting details-2026/3/13
2026-03-16查看详情 > -
Document: Template for scientific document for paediatric investigation plan or product-specific waiver-2026/4/16
2026-04-17查看详情 > -
Other: Question and answer document on the Guideline on assessment and control of DNA reactive (mutagenic) impurities in veterinary medicinal products (EMA/CVMP/SWP/377245/2016)-2023/01/27
2023-01-27查看详情 >
